Clinical Study

The Parkinson’S Progression Markers Initiative

Posted Date: Apr 8, 2015

  • Investigator: Alberto Espay
  • Co-Investigator: Kristy Espay
  • Specialties: Parkinson's Disease, Neurology, Movement Disorders
  • Type of Study: Observational/Survey

In this research study we will collect clinical information, samples of blood, DNA, urine, cerebral spinal fluid, and brain images from people with PD and from people without PD. This information will be used to help develop biomarkers for PD. Biomarkers are measures that tell something about PD. We are working on biomarkers in PD because they may help to understand how the disease changes over time. Having good biomarkers for PD may also be useful in developing new treatments and may help to improve clinical care in the future. In this study we will test biomarkers that may be related to the way PD changes over time. We will store information about all the tests and samples of the different fluids, such as blood, urine, spinal fluid, and DNA, for future testing.

Criteria:

You Are Being Invited To Take Part In This Study Because You Are At Least 30 Years Old And Thought To Have Early Parkinson Disease (Pd).

Keywords:

Biomarkers, Development, Origin And Cause Of Pd, Espay, Parkinson's Disease (Pd), Null

For More Information:

Kristy Espay
(513) 558-6517
sullivk5@ucmail.uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.